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Despite the importance of nitric oxide signaling in multiple biological processes, its role in 24 
tissue regeneration remains largely unexplored. Here, we provide evidence that inducible 25 
nitric oxide synthase (iNos) translocates to the nucleus during zebrafish tailfin regeneration 26 
and is associated with alterations in the nuclear S-nitrosylated proteome. iNos inhibitors or 27 
nitric oxide scavengers reduce protein S-nitrosylation and impair tailfin regeneration. Liquid 28 
chromatography/tandem mass spectrometry reveals an increase of up to 11-fold in the 29 
number of S-nitrosylated proteins during regeneration. Among these, Kdm1a, a well-known 30 
epigenetic modifier, is S-nitrosylated on Cys334. This alters Kdm1a binding to the CoRest 31 
complex, thus impairing its H3K4 demethylase activity, which is a response specific to the 32 
endothelial compartment. Rescue experiments show S-nitrosylation is essential for tailfin 33 
regeneration, and we identify downstream endothelial targets of Kdm1a S-nitrosylation. In 34 















Complete regrowth of functional tissue is a highly desirable, but mostly unachieved, 49 
therapeutic target in the tissue loss associated with many human diseases. Innate immune 50 
activation is an early response to tissue stress and injury 1. In lower vertebrates this is 51 
typically followed by functional tissue regeneration while in higher vertebrates there is 52 
normally fibrous scar formation 2. Although several molecular pathways have been 53 
implicated in tissue regeneration, the mechanisms underlying this process are still not clearly 54 
understood 3.  55 
The interaction between pattern recognition receptors (PRRs) and damage-associated 56 
molecular patterns (DAMPs) during and after an injury activates molecular pathways and 57 
transcriptional factors that regulate the expression of a plethora of genes. We have previously 58 
shown that this inflammatory signaling causes global changes in the expression and post-59 
translational modifications (PTM) of epigenetic modifiers favoring an open chromatin 60 
configuration and cellular plasticity 4,5. It was also found that inducible nitric oxide synthase 61 
(iNos) translocates to the nucleus to bind and S-nitrosylate the polycomb and NuRD 62 
complexes during trans-differentiation of fibroblasts into endothelial cells 6. The effect of cell 63 
autonomous innate immune signaling to increase DNA accessibility and thereby to facilitate 64 
nuclear reprogramming of cell fate is termed transflammation 7. The role of this phenomenon 65 
in tissue regeneration remains unexplored.  66 
Accordingly, here we investigated the role of the innate immune effector iNos and S-67 
nitrosylation of nuclear proteins in zebrafish tailfin regeneration, an ideal model to study 68 
appendage regeneration 8. We found that inos translocates from the cytoplasm to the nucleus 69 
in the regenerating tailfin and this is associated with an increase in S-nitrosylation of over 70 
500 different nuclear proteins. Of these, we demonstrated a strong link between Kdm1a S-71 
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nitrosylation and histone demethylase activity during tailfin regeneration, specifically in 72 
endothelial cells, the main target where S-nitrosylation mostly occurs and where the S-73 
nitrosylated form of Kdm1a promotes the expression of proangiogenic genes. Here, we show 74 
the essential role of the S-nitrosylation of nuclear proteins in tissue regeneration. 75 
 76 
Results 77 
Nos2 translocates from the cytoplasm to the nucleus and triggers protein S-nitrosylation 78 
during tailfin regeneration. 79 
Compared to mammals that have three nos genes (neuronal, or nos1; inducible, or nos2; and 80 
endothelial, or nos3), the zebrafish genome has only nos1 and two nos2 genes (nos2a and 81 
nos2b). Activation of the innate immune system transcription factor Nf-kb following injury 82 
triggers the translocation of the kB subunit into the nucleus which in turn promotes activation 83 
of a panoply of genes, including inos 9. The activation of Nf-kb after tailfin amputation was 84 
measured as GFP signal in the Tg(nfkb:EGFP)nc1 zebrafish (Fig. S1A-B). Real time PCR for 85 
nos genes measured in the adult zebrafish (Danio rerio) tailfin uninjured (baseline) and at 3, 86 
5 and 10 days post-amputation (dpa) revealed a significant increase of nos2b expression and 87 
a slight increase in nos1 at 3 and 5 dpa (Fig. 1A). Increased nos2 expression during 88 
regeneration was confirmed by western blotting (WB) (Fig. 1B). To confirm the role of Nf-89 
kb on the upregulation of nos2, adult zebrafish were injected with the Nf-kb inhibitor Bay11-90 
7082 30 mM, which resulted in a reduced expression of nos2b in the injured tailfin (Fig. 91 
S1C) at 3 and 5 dpa compared to injured control. While iNos has been considered 92 
predominantly cytosolic, it has also been localized to other cellular compartments, including 93 
the nucleus 6. Analysis of Nos2 compartmentalization in the uninjured tailfin confirmed a 94 
predominantly cytoplasmic distribution of this protein (Fig. 1C). However, at 3 dpa Nos2 95 
 5
was predominantly in the nucleus, with equal distribution between nucleus and cytoplasm at 96 
5 dpa, returning predominantly to the cytoplasm by 10 dpa, similar to uninjured controls. 97 
Thus, immediately after injury, Nos2 translocates to the nucleus and, during later stages of 98 
repair, shifts back to the cytoplasm. This key series of observations gave rise to our principal 99 
hypothesis, namely, that changes in the distribution of Nos2 during regeneration mirror and 100 
drive changes in S-nitrosylation of nuclear proteins.  101 
To address this, we collected newly formed tissue at the wound edge for extraction of nuclear 102 
protein after amputation of adult zebrafish tailfins. Separation of nuclear proteins was 103 
confirmed by western blotting to detect nuclear and cytoplasmic markers (Fig. S1D).  The 104 
nuclear fractions were treated with iodoacetyl Tandem Mass Tags (iodoTMT) to label S-105 
nitrosylated proteins, and were subsequently identified using an anti-TMT antibody. Western 106 
blotting revealed an increase in the number and intensity of protein bands in the regenerating 107 
tissue compared to control tissue, suggesting an S-nitrosylation switch in nuclear proteins 108 
(Fig. 1D). When zebrafish were injected in the retro-orbital vein with increasing 109 
concentrations of the Nos inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME) or the NO 110 
scavenger 2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO), the levels of 111 
protein S-nitrosylation were reduced (Fig. 1E), whereas treatment with increasing 112 
concentrations of the NO donor S-Nitroso-N-acetyl-DL-penicillamine (SNAP) increased 113 
protein S-nitrosylation (Fig. 1E). L-NAME and PTIO significantly reduced tailfin 114 
regeneration compared to control or SNAP treated groups at 3 and 7 dpa (Fig. 1F and S2A). 115 
As L-NAME inhibits all Nos isoenzymes, in order to assess the specific role of iNos we 116 
treated the tailfin regeneration model with the iNos selective inhibitor 1400W 10. Treatment 117 
with 1400W 50 mM reduced tailfin regeneration in a manner similar to L-NAME, suggesting 118 
that Nos2 is the main Nos isoenzyme involved in the effect observed by L-NAME (Fig. 119 
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S2A). Overall, these results indicate that Nos2 and NO are necessary for tailfin regeneration 120 
and that protein S-nitrosylation plays a key role in this process. 121 
 122 
Analysis and screening of S-nitroso-proteome revealed an increase in S-nitrosylated nuclear 123 
proteins during tailfin regeneration.  124 
To identify nuclear proteins that were S-nitrosylated during regeneration, we performed 125 
liquid chromatography and tandem mass-spectrometry (LC/MS/MS) (Fig. 2A) on protein 126 
extracts from the tailfin wound edge, excised at 3, 5 and 10 dpa. Hierarchical clustering 127 
showed a striking increase in the number of nuclear S-nitrosylated proteins during 128 
regeneration, in particular at 5 dpa (Figs. 2B and S3).  We found that the number of nuclear 129 
S-nitrosylated proteins increased from 31 in uninjured to 199, 351 and 264 at 3, 5 and 10 dpa, 130 
respectively (Fig. 2C). Taking account of the fact that some proteins changed their S-131 
nitrosylation state on more than one cysteine residue of that protein, the actual total number 132 
of S-nitrosylated peptides increased from 31 in uninjured to 332, 566 and 450 at 3, 5 and 10 133 
dpa, respectively (Fig. S3A). While a few proteins were S-nitrosylated throughout these time-134 
points, suggesting constitutive S-nitrosylation, the analysis revealed that the majority of the 135 
proteins were modified uniquely at a specific time-point. These data strongly suggest a 136 
dynamic choreography of S-nitrosylation throughout the regeneration process. Indeed, an 137 
analysis of differential enrichment revealed that proteins of many different pathways are S-138 
nitrosylated specifically during regeneration (Fig. 2D). Some of these are known to be 139 
implicated in developmental and wound healing processes, such as the epithelial–140 
mesenchymal transition (EMT) pathway 11 and the Hedgehog pathway 12. From the protein 141 
list (Dataset S1), we selected 31 candidates, encompassing epigenetic modifiers and 142 
transcription factors for which transient S-nitrosylation have not been previously reported and 143 
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that have a human ortholog (Table S1). We proceeded to analyse these by deep mass-144 
spectrometry, focusing initially on Kdm1A, also known as Lsd1, Kiaa061 or Aof2 145 
(UniProtKB - F6NIA2). 146 
 147 
S-nitrosylation of Kdm1a is associated with a reduced binding to the CoREST complex and 148 
impaired demethylase activity on H3K4 during tailfin regeneration. 149 
Kdm1a was the first histone lysine-demethylase to be described 13, where an amine oxidase 150 
domain mediates its FAD-dependent demethylase activity 14. Kdm1a participates in gene 151 
repression as part of the CoREST (co-repressor for element-1-silencing transcription factor)15 152 
and NuRD (nucleosome remodeling and histone deacetylation)16 co-repressor complexes 153 
mediating the demethylation of H3K4me1/me2. It also participates in gene activation in 154 
androgen receptor (Ar)-driven expression programs through demethylation of repressor 155 
marks H3K9me1/me2 1718.  More recently, it has been demonstrated that Kdm1a is also able 156 
to demethylate lysine residues at several non-histone substrates, such as p53 19, Dnmt1 (DNA 157 
(cytosine-5)-methyltransferase 1) 20 and E2F1 21.  158 
Mass-spec revealed that Kdm1a, although detectable in the nucleus at all three time-points, 159 
becomes S-nitrosylated on Cysteine 334 (Cys334) at 3 and 5 dpa (Fig. 3A-B). The increase 160 
of Kdm1a S-nitrosylation (S-NO) during tailfin regeneration was confirmed by western 161 
blotting for S-NO on samples previously immunoprecipitated for Kdm1a (Fig. 3C). Zebrafish 162 
Kdm1a protein has 85% identity with the corresponding human gene with the Cys334 163 
corresponding to Cys360 in the human ortholog (Fig. S4A). Intriguingly, the sequence of 60 164 
amino acids (aa) from 50 upstream to 9 downstream of the Cys334 retains 100% identity with 165 
the human ortholog. Human KDM1a crystal structure, obtained from Protein Data Bank 166 
deposited by Tan et al.22, is shown in Fig. S4B. 167 
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The selectivity of Kdm1a for its main targets, H3K4 and H3K9, depends on its interaction 168 
with specific protein co-factors, including CoREST, NuRD, and Ar. PTM can modulate these 169 
interactions. Therefore, first we analysed these co-factors and their complexes in injured and 170 
uninjured tailfins. Expression of CoREST and NuRD were unchanged in injured and 171 
uninjured tailfin (Fig. S5). The expression of ar was extremely low and was not different in 172 
injured versus uninjured tailfin (Fig. S5). Having established the patterns of expression of 173 
these co-factors, and since ar is associated with the modulation of H3K9, we decided to focus 174 
on H3K4 which is known to be linked to CoREST and NuRD.  175 
Hence, focusing on NuRD and CoREST, we tested the hypothesis that S-nitrosylation of 176 
Cys334 affects Kdm1a binding affinity to these complexes. To do this, we performed co-177 
immunoprecipitation with Kdm1a antibody (Fig. 3D), followed by WB for the members of 178 
the CoREST (Rcor1 and Hdac1) (Fig. 3E) and NuRD (Rbbp4 and Chd4) (Fig. 3F) 179 
complexes. While the binding of NuRD complex was similar during regeneration compared 180 
to control, the binding to the CoREST complex was reduced. 181 
To further assess the role of Kdm1a in the adult zebrafish, knockdown (KD) was achieved by 182 
injection of morpholino (vivo-Mo) in the retro-orbital vein. The KD efficiency as well as 183 
delivery to the tailfin was assessed by western blotting for Kdm1a (Fig. 4A). We saw clear 184 
evidence that kdm1a KD by vivo-Mo injection impaired tailfin regeneration compared to 185 
controls (Fig. 4B-C). A dynamic and choreographed regulation of kdm1a expression and 186 
activity therefore appears to be essential for tissue regeneration. These data support the role 187 
of Kdm1a as a key regulator of regeneration, likely through modulation of chromatin 188 
modifications. 189 
During tailfin regeneration we observed a significantly reduced demethylase activity of 190 
Kdm1a in the regenerating tailfin associated with increased levels of Kdm1a S-nitrosylation 191 
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(Fig. 3B). This reduced Kdm1a activity was similar to that observed in zebrafish kdm1a KD 192 
(Fig. S6). 193 
Indeed, at the same time that Kdm1a activity was reduced, there was a corresponding 194 
reduction in unmethylated H3K4 (Fig. 4D-E). By contrast, there was an increase in 195 
H3K4me1/me2, normally associated with active gene transcription (Fig. 4D-E). H3K4me3 196 
showed a pattern similar to H3K4me2. However, it is known that Kdm1a is unable to 197 
demethylate H3K4me3, according to the chemical nature of the amine oxidation reaction 198 
catalyzed by flavin-containing amine oxidases, thus precluding H3K4me3 as a substrate 13.  199 
In regenerating tailfins, the blastema, a pool of proliferative progenitor cells, is located at the 200 
distal region of the tailfin while cells in the proximal region undergo differentiation. To 201 
localise the region in which Kdm1a S-nitrosylation is most important, we analysed the 202 
expression of kdm1a gene in the distal (blastema) and proximal regions (differentiating zone) 203 
of regenerating tailfins at 3 and 5 dpa. Compared to uninjured tailfins, kdm1a expression was 204 
significantly lower in the blastema and only slightly reduced in the proximal differentiating 205 
zone (Fig. S7A). We also took advantage of a publicly available single cell(sc) RNA-seq 206 
dataset obtained in the regenerating tailfin 23 in which kdm1a expression was detected, at low 207 
levels, with a distinct expression pattern observed in specific cell types (Fig. S7B). For 208 
example, compared to preinjury, the kdm1a expression was reduced in mucosal-like cells at 1 209 
and 2 dpa followed by an increase at 4 dpa, it was increased in mesenchymal cells and it was 210 
not expressed in hematopoietic cells during the regeneration. Overall, this data provides 211 
further evidence that modulation of S-nitrosylation, as well as modulation of gene expression, 212 
is a key mechanism regulating the functionality of Kdm1a during tailfin regeneration.  213 
 214 
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Kdm1a is S-nitrosylated preferentially in the endothelial cells of the regenerating tailfin. 215 
Next, we identified S-nitrosylation associated with specific cell type.  The formation of new 216 
blood vessels is a crucial process during wound healing and tissue repair, similar to 217 
embryogenesis and early growth. During tailfin regeneration, endothelial cells within the 218 
growing blood vessels sprout and invade adjacent avascular areas. By using the 219 
Tg(fli1:EGFP)y1 zebrafish line, where endothelial cells (EC) fluoresce green (GFP+ cells), we 220 
detected the formation of new blood vessels in the regenerating tailfin at 2 dpa that become a 221 
dense vascular plexus by 3 dpa (Fig. 5A) consistent with previous observations 24. We 222 
isolated EC from these tailfins and performed FACS analysis. We found an increase in the 223 
percentage of EC (GFP+) from 4.3± 0.3 % to 6.1 ± 0.4 %, in the uninjured versus injured 224 
tailfin, respectively (Fig. 5B-C and S7C). We FACS purified GFP+ (EC) and GFP- (non-EC) 225 
from injured and uninjured tailfins, extracted RNA and performed real time PCR. For kdm1a, 226 
we found no difference in gene expression between groups (Fig. S8A). We also analysed the 227 
expression of CoREST (rcor1 and hdac1) and NuRD (rbbp4 and chd4) factors and did not 228 
detect significant differences between groups (Fig. S8B-E). In response to stress or injury, 229 
EC upregulate inos, with consequent NO production 25. We found an upregulation of nos2b 230 
compared to nos2A and nos1 genes in the EC of injured tailfins compared to uninjured (Fig. 231 
S8F-H). Therefore, we investigated if S-nitrosylation, more specifically of Kdm1a, occurs in 232 
EC during tailfin regeneration. We observed an overall increase in S-nitrosylated proteins in 233 
the EC of regenerating tissue compared to EC from uninjured tissue (Fig. 5D), with no 234 
change in S-nitrosylated proteins in GFP- cells from injured versus uninjured tailfins. Then, 235 
we specifically analysed S-nitrosylated Kdm1a in EC cells from injured and uninjured tailfins 236 
at 5 dpa, including an injured group treated with the nitric oxide (NO) scavenger PTIO. 237 
While the expression of total kdm1a did not change in the three groups, S-nitrosylated 238 
Kdm1a was detectable in EC from regenerating tailfin only (Fig. 5E), while it was abolished 239 
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in the group treated with PTIO. The increased S-nitrosylation of Kdm1a in EC of the 240 
regenerating tailfin was associated with a significant increase in vessel density compared to 241 
the other two groups (Fig. 5F). 242 
 243 
S-nitrosylation of Kdm1a is associated with increased H3K4me2 marks for endothelial genes 244 
during tailfin regeneration. 245 
As shown in Fig. 4D-E, H3K4me2, a target of Kdm1a, is increased during regeneration 246 
associated with the reduced demethylase activity of the S-nitrosylated form of Kdm1a. 247 
Methylated H3K4 is associated with active gene transcription. Accordingly, we reasoned that 248 
an increased occupancy of H3K4me2 would result in increased levels of proangiogenic 249 
factors. To address this hypothesis, and investigate whether the increased vessel density 250 
observed during regeneration was correlated to S-nitrosylation of Kdm1a, we performed 251 
Chromatin Immunoprecipitation using a ChIP-grade antibody specific for H3K4me2, 252 
followed by PCR for 10 well-known proangiogenic factors, including kdr, vegfaa, fgf2, 253 
angpt2, tek, tie1, cdh5, cd31, mmp2 and tbx20. ChIP-PCR showed that the occupancy of 254 
H3K4me2 on vegfaa and tek in endothelial cells from injured tailfins was significantly higher 255 
compared to injured tailfins treated with PTIO and higher than uninjured tailfins (Fig. 5G). 256 
Furthermore, real time PCR showed that expression of 7 out of 10 proangiogenic factors, 257 
including vegfaa and tek, were significantly increased during regeneration (Fig. 5H), whereas 258 
they were unchanged following treatment with PTIO, again suggesting that nitric oxide was 259 
driving or facilitating angiogenesis via a mechanism involving S-nitrosylation. 260 
Overall, these findings show that endothelial cells of the regenerating tissue are a key cell 261 
target for protein S-nitrosylation after injury and that Kdm1a is specifically S-nitrosylated in 262 
these cells. S-nitrosylation of Kdm1a reduces Kdm1a demethylase activity and, as a 263 
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consequence, more H3K4me2 will accumulate in the genome. In particular, we found 264 
increased occupancy of H3K4me2 on vegfaa and tek.  265 
This does not exclude, however, that other S-nitrosylated proteins among those arising from 266 
the mass-spec dataset could be implicated in endothelial cells and vascular regrowth as well 267 
as in other cell types. 268 
Next, to investigate the effects of the absence of the Kdm1a C334 S-nitrosylation site on 269 
tailfin regeneration we synthesized, by site-directed mutagenesis, a mutant variant of Kdm1a 270 
mRNA where the cysteine 334 was substituted with alanine (C334A), that cannot be S-271 
nitrosylated (Fig. 6A). These experiments assessed the ability of this mutated Kdm1a mRNA 272 
to rescue the morpholino (Mo) phenotype compared to wild-type mRNA. However, contrary 273 
to the MO oligo that is a stable molecule, not degraded by the nucleases, the mRNA is prone 274 
to degradation by nucleases, well before reaching the tailfin, i.e. the tissue under study. 275 
Therefore, we decided to perform these studies in the zebrafish embryos where the 276 
cytoplasmic bridges connecting the early embryonic cells allow rapid diffusion of mRNA 277 
into the cells, resulting in fast and ubiquitous delivery 26. 278 
Before the morpholino (Mo) studies, real time PCR analysis confirmed kdm1a expression 279 
during development, with a slight reduction from 24 to 120 hpf (Fig. S9A). This finding was 280 
also useful to optimise the dose of Mo to inject. Mo experiments were conducted according 281 
to the guidelines 2627 using several controls to assess morpholino specificity for kdm1a. First, 282 
we injected kdm1a-targeted Mo or the mismatch (control), using an optimized dose of 0.8 ng 283 
per egg. The effective kdm1a KD was confirmed by western blotting (Fig. 6B). The survival 284 
rate of kdm1a KD embryos at 120 hpf was approximately 80 % compared to 90 % in controls 285 
(Fig. S9C). Kdm1a KD embryos did not show gross abnormalities compared to control (Fig. 286 
S9D), however we found reduced blood flow velocity (Fig. S9E) and reduced expression of 287 
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gata1 (Fig. S9F), a red blood cell marker, consistent with a previous report 28. To confirm 288 
these effects and to exclude sequence-specific off-target effects we used a second Mo with 289 
non-overlapping sequence to compare phenotypes with the first Mo. Indeed, both Mo 290 
injections induced kdm1a knockdown and produced a comparable phenotype. To further 291 
confirm the specificity, we co-injected half-doses of each Mo, such that the phenotype was 292 
only just apparent with each Mo alone, but with clear additive effects on phenotype when co-293 
injected. Specifically, the two kdm1a -targeted antisense Mo were co-injected each at 1/2 294 
dose (0.4 ng per egg). While the phenotype was apparently unaffected with 1/2 dose of each 295 
oligo injected alone, the co-injection of half doses together produced phenotypic effects 296 
similar to those produced by a single oligo at full dose (0.8 ng per egg) (Figs. 6B and S9). 297 
These additive effects of low doses of two antisense oligos strongly supports a kdm1a -298 
specific effect. We did not find an increase in expression of tp53, well-known off-target 299 
effect, at the dose of Mo used in this study, therefore we did not co-inject tp53-Mo for tp53 300 
gene silencing (Fig. S9B). We observed that the regeneration of the tailfin was significantly 301 
reduced in kdm1a KD embryos compared to control (Fig. 6C-D), with a phenotype 302 
penetrance of >70%. The phenotype of kdm1a morphants was rescued by co-injecting kdm1a 303 
mRNA indicating that the observed effects were specific for kdm1a. This also clearly shows a 304 
key role of kdm1a in tailfin regeneration. However, kdm1a mRNA C334A did not rescue 305 
tailfin regeneration (Fig. 6C-D and Fig. S9). This further confirmed the crucial role of S-306 
nitrosylation of this specific cysteine residue on Kdm1a in modulating tailfin regeneration.  307 
 308 
Discussion 309 
Following stress or injury, inos is activated within local somatic cells 29, leading to protein S-310 
nitrosylation, the covalent attachment of a NO group to the thiol side chain of the cysteine.  311 
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This mechanism has emerged as a dynamic, post-translational regulatory mechanism for 312 
many classes of proteins 30. We found increased expression of inos in the nuclei of the 313 
regenerating tailfin of the zebrafish, and over 500 nuclear proteins that became S-nitrosylated 314 
during regeneration. Of these, we identified a key role for Kdm1a. We demonstrated a strong 315 
link between Kdm1a S-nitrosylation and its role in histone demethylation and ultimately in 316 
regeneration of the zebrafish tailfin. Endothelial cells, where inos expression increases after 317 
stress or injury, seems to be the main cell target where S-nitrosylation, including of Kdm1a, 318 
mostly occurs. The essential role of Kdm1a in hematopoiesis has been shown in vitro 3132 and 319 
in vivo 33,34. As such, understanding the molecular mechanisms underpinning the action of 320 
Kdm1a are currently being investigated to find specific inhibitors that could be harnessed as a 321 
therapeutic strategy in cancer 35. According to our bioinformatic analysis of single cell-322 
RNAseq, kdm1a was not detected in hematopoietic cells of the zebrafish regenerating tailfin. 323 
Nonetheless, given the role of the Kdm1a in hematopoiesis we cannot exclude the possibility 324 
that impaired fin regeneration in kdm1a knockdown zebrafish could, at least partially, derive 325 
from systemic effects associated with altered immune cell function. 326 
In our study, the S-nitrosylated form of Kdm1a has a reduced demethylase activity on H3K4 327 
that results in a corresponding increase in H3K4me2 that, by turn, promotes the expression of 328 
proangiogenic genes. This is the first study to show the importance of the S-nitrosylation of 329 
nuclear proteins in tissue regeneration and potentially opens up new therapeutic avenues (Fig. 330 
6E).  331 
While many interesting candidate S-nitrosylated nuclear proteins were identified (Dataset S1 332 
and Table S1), we focused on Kdm1a. However, we predict that it is likely that Kdm1a is 333 
not the only rate limiting factor. It is likely that modulating the expression and S-nitrosylation 334 
of other candidates could result in similar effects on regeneration, possibly by acting via the 335 
same cells and pathways identified here but possibly on other cell types and pathways.  This 336 
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would depend on the effects that S-nitrosylation has on molecular networking of each protein 337 
candidate. For example, S-nitrosylation of Hexim1 (hexamethylene bisacetamide inducible 338 
protein 1) could affect its binding in the P-TEFB complex 36 and potentially inhibits the Cdk9 339 
kinase activity and the transcription of genes specific to regeneration.    340 
Aberrant levels of protein S-nitrosylation have been implicated in a number of diseases, 341 
including heart disease, diabetes, cancer, neurological disorders, chronic degenerative 342 
diseases, and inflammatory disorders (reviewed in 37), regeneration. Furthermore, very little 343 
is known about two important aspects of this process, firstly the extent and the dynamics of 344 
S-nitrosylation of nuclear proteins in human disease and secondly the role of  S-nitrosylation 345 
of nuclear proteins during tissue  repair and regeneration 38. Our paper is the first to examine 346 
the mechanisms and potential role of S-nitrosylation of nuclear proteins during tissue 347 
regeneration in vivo and provides several important observations that implicate S-348 
nitrosylation of nuclear proteins in regeneration.  349 
Methods 350 
Ethical approval 351 
This work complied with all relevant ethical regulations for animal testing and research. 352 
Animals were housed and all experiments were carried out in accordance with the 353 
recommendations of the Institutional Animal Care and Use Committee at the Houston 354 
Methodist Research Institute, and with the United Kingdom Animals (Scientific Procedures) 355 
Act 1986 at the Queens Medical Research Institute research facilities. 356 
 357 
Zebrafish aquaculture and husbandry 358 
Adult zebrafish – wild-type Wik and Tg(nfkb:EGFP)nc1 strains – were maintained according 359 
to standard procedures. Fish were kept at 28 ̊C under a 14/10 h light/dark cycle and fed with 360 
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dry meal (Gemma Micro, Westbrook, ME) twice per day. Embryos were obtained by natural 361 
mating and kept in E3 embryo medium at 28.5 ̊C. Surgical procedures were performed under 362 
anaesthesia with Tricaine (also named MS-222, Sigma-Aldrich, St Louis, MO, cat. E10521) 363 
0.02 mg/ml on embryos and 0.05 mg/mL in adult zebrafish. 364 
 365 
Zebrafish tailfin amputation and regeneration 366 
Caudal tailfin amputation surgeries were performed as previously described 39. Briefly, fish 367 
were anaesthetized and amputations were made by using a sterile razor blade, removing half 368 
of the tailfin. At day 3, 5 and 10 post-amputation (dpa) (uninjured tailfin was used as control) 369 
the regrown tissue was carefully resected and immediately processed for nuclear protein 370 
extraction.  Total regeneration was measured as previously described 40. Briefly, fin images 371 
were collected before amputation and time points after amputation. The new tissue area (in 372 
pixels) of the caudal fin from the new distal fin edge to the amputation plane was quantified 373 
in each fish using Image J software. The percentage of regeneration for each fin at each time 374 
point was defined as percentage of regeneration = 100 x (regenerated tissue area/original fin 375 
area amputated). The collection of the distal (blastema) and proximal (regenerating) regions 376 
of the tailfin tissue for PCR analysis was performed under a fluorescence stereomicroscope 377 
Leica M205. The Tg(fli1:EGFP) zebrafish was used and the distal ends of the newly forming 378 
(GFP+) vessel branches was used as boundary to separate by dissection the two regions. 379 
Then, we placed the tissues in an Eppendorf tube and immediately extracted RNA that was 380 
used for PCR analysis. 381 
 382 
Blood vessel density 383 
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At 5 dpa, the adult Tg(fli1:EGFP) zebrafish were anesthetized. Then, fish were transferred on 384 
a wet sponge, previously soaked in tank water, to keep the zebrafish skin moist during 385 
imaging. Images of the caudal fin including the regenerated tissue were captured under a 386 
fluorescence stereomicroscope Leica M205 equipped with a camera. The images were 387 
collected with a Leica LAS X software and analysed by Image J software. The second and 388 
third rays from the dorsal edge of the fin were used for measurement of vessel area and 389 
reported as mm2.  390 
 391 
Protein Extraction  392 
Extraction of nuclear proteins - Nuclear proteins were extracted from the caudal fin tissue 393 
using the NE-PER Extraction Reagents kit (Thermo Fisher Scientific, San Jose, CA, cat. 394 
78833) according to the manufacturer’s instructions, supplemented with protease inhibitor 395 
cocktail. In brief, regenerating tailfin tissue was resected, cut into small pieces and placed in 396 
a microcentrifuge tube. Then, tissue was washed three times with chilled PBS, centrifuged at 397 
500g for 1 min and supernatant discarded. Using a motor-driven pestle (Sigma-Aldrich, St 398 
Louis, MO, cat. Z359971), tissue was homogenized in solution CER I, that breaks plasma 399 
membrane but not nuclei, added with protease/phosphatase inhibitors cocktail (1:100, 400 
Thermo Fisher Scientific, San Jose, CA, cat. 78442). The tube was vigorously vortexed for 401 
30 s and put on ice for 10 min. Then, chilled CER II was added to the tube, vortexed for 10 s 402 
and incubated on ice for 1 min. The tube was centrifuged for 5 min at 16,000g and the 403 
supernatant, containing cytoplasmic proteins, was transferred to a clean pre-chilled tube and 404 
stored at -80 ̊C. The pellet, containing nuclei, was resuspended in chilled NER solution, 405 
vortexed on the highest setting for 15 s. The sample was placed on ice for 45 min, vortexed 406 
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for 20 s every 10 min. Then, the tube was centrifuged at 16,000g for 10 min and the 407 
supernatant, containing nuclear extract, immediately transferred to a clean pre-chilled tube.  408 
Extraction of total proteins - Zebrafish embryos were euthanised with an overdose of 409 
tricaine, washed three times in PBS and homogenized with a motor-driven pestle (Sigma-410 
Aldrich, St Louis, MO, cat. Z359971) in 100 mL RIPA buffer (25 mmol/L Tris-HCl pH 7.6, 411 
150 mmol/L NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS), supplemented with 412 
protease/phosphatase inhibitors. The lysate was kept on ice for 40 min. Then, the tube was 413 
centrifuged at 3000g for 5 min and the supernatant transferred to a clean pre-chilled tube.  414 
In both nuclear and total proteins extraction, bicinchoninic acid (BCA) protein assay (Thermo 415 
Fisher Scientific, San Jose, CA, cat. 23225) was used to measure protein concentration. 416 
 417 
Labelling of protein S-nitrosothiols 418 
Labelling of S-nitrosothiols in nuclear proteins was achieved using Iodoacetyl Tandem Mass 419 
Tag (iodoTMT) kit (Thermo Fisher Scientific, San Jose, CA, cat. 90103). First, nuclear 420 
protein extracts were acetone-precipitated at -20°C for 2 h, then centrifuged at 15000g for 10 421 
min and the pellet solubilized in 500 mL HENS buffer (Thermo Fisher Scientific, San Jose, 422 
CA, cat. 90106) at a protein concentration of 1 mg/ml. Equal amounts of nuclear protein from 423 
each sample were iodoTMT-labelled. To generate a positive control sample, an aliquot of 424 
protein from control was added with 200μM S-nitrosoglutathione (GSNO, Sigma-Aldrich, St 425 
Louis, MO, cat. N4148) for 30 min at room temperature (RT). Experimental samples were 426 
incubated for 30 min at RT after adding MMTS (10μL of 1 M) to block free cysteine thiols. 427 
Then, proteins were precipitated with pre-chilled acetone (1 ml per sample) at -20°C for 2 h 428 
to remove MMTS. Samples were centrifuged at 10,000g for 10 min at 4°C, the pellet 429 
resuspended in 500 ml of HENS buffer and to each was added 5 ml of iodoTMT reagent, 430 
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previously dissolved in liquid chromatography/mass spectrometry (LC/MS)-grade methanol, 431 
and 10μL of 1M sodium ascorbate (Sigma-Aldrich, St Louis, MO, cat. A4034). As a negative 432 
control, 10μL of ultrapure water instead of sodium ascorbate was added in a protein sample. 433 
All samples were incubated for 1 h at 37°C, protected from light. The reaction was quenched 434 
by adding 20 μL of 0.5M DTT and incubated for 15 min at 37°C, protected from light. All 435 
experimental samples labelled with iodoTMT sixplex were combined, added with six 436 
volumes of pre-chilled acetone and incubated at -20°C overnight. The sample was 437 
centrifuged at 10,000g for 10 min at 4°C and the pellet dissolved in 3 ml HENS buffer. Then, 438 
100μL of 0.5 M iodoacetamide were added and the sample incubated at 37°C for 1 h 439 
protected from light. Sample was precipitated with pre-chilled acetone and the pellet allowed 440 
to dry for 10 min. 441 
 442 
Protein digestion for mass-spec analysis  443 
The pellet was dissolved in 50mM ammonium bicarbonate (Sigma-Aldrich, St Louis, MO, 444 
cat. 09830) and digested using trypsin enzyme (GenDepot, cat. T9600) at 37oC overnight. 445 
The peptide mixture was acidified using 10% formic acid and dried using a vacuum 446 
concentrator (Thermo Fisher Scientific, San Jose, CA, cat. SPD120).  447 
 448 
Enrichment of iodoTMT-labeled S-nitrosopeptides  449 
The anti-TMT Antibody Resin (Thermo Fisher Scientific, San Jose, CA, cat. 90076) was 450 
washed three times with Tris Buffered Saline (TBS) (Thermo Fisher Scientific, San Jose, CA, 451 
cat. 28358). Previous labeled and lyophilized peptides were resuspended in TBS (a small 452 
portion of unfractionated sample was stored for direct analysis of the non-enriched samples). 453 
Then, peptides were added to the anti-TMT resin (100μL of settled resin for every 1 mg of 454 
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iodoTMT Reagent-labeled peptides) and incubated at RT for 4 h. Finally, the resin was 455 
washed three times (5 min per wash) with TBS and then three times with water. The sample 456 
was eluted with TMT Elution Buffer (Thermo Fisher Scientific, San Jose, CA, cat. 90104). 457 
The eluate was frozen and lyophilized, using a vacuum concentrator and then the sample 458 
resuspended in a solution of 5% methanol/0.1% formic acid. Then, 1-5μL of sample were 459 
injected directly onto an LC-MS/MS system. 460 
 461 
LC/MS-MS 462 
The mass spectrometry analysis of S-nitrosopeptides was carried out on a nano-LC 1200 463 
system (Thermo Fisher Scientific, San Jose, CA) coupled to Orbitrap Fusion™ Lumos ETD 464 
(Thermo Fisher Scientific, San Jose, CA) mass spectrometer. The peptides were loaded onto 465 
a Reprosil-Pur Basic C18 (1.9 µm, Dr. Maisch GmbH, Germany) pre-column of 2 cm X 100 466 
µm and in-lined an in-housed 5 cm x 150 µm analytical column packed with Reprosil-Pur 467 
Basic C18 beads. The peptides were separated using a 75 min discontinuous gradient of 5-468 
28% acetonitrile/0.1% formic acid at a flow rate of 750nl/min. The eluted peptides were 469 
directly electro-sprayed into the mass spectrometer. The instrument used the multi-notch 470 
MS3-based TMT method. The full MS scan was performed in Orbitrap in the range of 375-471 
1500m/z at 120000 resolution followed by ion trap CID-MS2 fragmentation at precursor 472 
isolation width of 0.7 m/z, AGC of 1X104, maximum ion accumulation time of 50ms. The 473 
top ten fragment ions from MS2 was selected for HCD-MS3 with isolation width of 2 m/z, 474 
AGC 5X104, collision energy 65%, maximum injection time of 54ms. The RAW file from 475 
mass spectrometer was processed with Proteome Discoverer 2.1 (Thermo Fisher Scientific, 476 
San Jose, CA) using Mascot 2.4 (Matrix Science) with percolator against Zebrafish Uniprot 477 
database. The precursor ion tolerance and product ion tolerance were set to 20 ppm and 478 
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0.5Da respectively. Variable modifications of oxidation on Methionine (+15.995Da) and 479 
iodoTMT tag (+329.2266Da) on cysteine residues was used. The general quantification in 480 
consensus workflow used unique and razor peptides with top 3 peptides for area calculation, 481 
while reporter quantification used co-isolation threshold of 50 and average reporter S/N 482 
threshold of 10. The assigned peptides and PSMs were filtered at 1% FDR. 483 
 484 
Bioinformatic analysis 485 
The computational detection strategy identifies peptides exhibiting iodoTMT tag 486 
modifications. Proteome Discoverer software (Thermo Fisher Scientific, San Jose, CA) was 487 
used to search MS/MS spectra against the Zebrafish UniProt database (Danio rerio; 488 
UP000000437) using Mascot 2.3 search engine. The iodoTMTsixplex quantification method 489 
within Proteome Discoverer software was used to calculate the reporter ratios with a mass 490 
tolerance ±10 ppm. Search algorithms, including MS-Fragger was also used in the analysis. 491 
Hierarchical clustering of S-nitrosylated protein expression heatmap was conducted using 492 
MEV based on Pearson correlation distance metric and the average linkage method. 493 
Ingenuity pathway analysis (IPA, Ingenuity systems Qiagen, Redwood City, CA) was used to 494 
assess Gene Ontology (GO) and IPA analysis to explore the function of differential S-495 
nitrosylated proteins. Enrichment Q values of S-nitrosylated protein pathways were defined 496 
based on EdgeR FDR cutoff 1e-5. The GO category was classified by Fisher’s exact test, and 497 
the p-value was corrected by the false discovery rate (FDR) calculation. 498 
The scRNA-seq of the regenerative caudal fin was analysed following the methods described 499 
in the manuscript 23. The matrix count from cell ranger were obtained on GEO database 500 
accession GSE137971. Downstream analysis was performed on R using the package Seurat. 501 
Clustering analysis was performed on the integrated dataset and we found 6 clusters. These 502 
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clusters were annotated as Superficial/intermediate/basal epithelial, mucosal-like, 503 
hematopoietic and mesenchymal based on markers described in Hou et al. 23. Differential 504 
gene expression between the different time points compared to pre-injury was done using the 505 
function FindMarkers from Seurat (based on Wilcoxon test followed by Bonferroni 506 
correction). Violin Plot of kdm1a expression was obtained using the Vln Plot function of 507 
Seurat. 508 
 509 
Chromatin immunoprecipitation (ChIP)-PCR assay 510 
ChIP assay was performed following the manufacturer’s instructions (Cell Signalling 511 
Technology, Beverly, MA). Briefly, 15 tailfins of adult zebrafish per group were 512 
disaggregated in single cells as described above. DNA and protein were crosslinked by 1% 513 
formaldehyde. Chromatin was isolated and digested with Micrococcal Nuclease. Then, the 514 
DNA-protein complex was precipitated with control IgG or antibody against H3K4me2 515 
(rabbit polyclonal, ChIP grade) overnight at 4°C and protein A/G conjugated magnetic beads 516 
for 1 hr. Cross-links were reversed. The extracted DNA was used as template for PCR 517 
amplification of the targeted promoter region. The extracted DNA from unprecipitated DNA-518 
protein complex was used as input. The promoter regions of 10 genes known to be involved 519 
in neoangiogenesis (kdr, vegfaa, cdh5, tek, tie2, tbx20, fgf2, angpt2, mmp2, cd31) were 520 
identified in ENSEMBL. The gene sequence up to 600 bp upstream of the TSS was validated 521 
this sequence on genome.ucsc.edu to confirm it was upstream of our gene of interest. We also 522 
looked for the presence of CpG islands and TATA box. Hence, we designed four couples of 523 
primers using Primer Blast for each gene that matched in this region and around the TSS, and 524 
that could generate amplicons which size was no more than 120-130 bp to allow both primers 525 
to find their target on one fragment of ChIP DNA, if present. In-silico PCR (UCSC) was used 526 
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to confirm that primers matched our region of interest and the amplicon size, and then 527 
primers were further validated by PCR using genomic DNA.  528 
 529 
Quantification of Kdm1a demethylase activity 530 
Kdm1 Activity Colorimetric Kit (Abcam, Cambridge, UK, cat. ab113459) was used to 531 
quantify Kdm1 activity. Nuclear proteins were extracted from the regenerating caudal fin as 532 
shown above and an input of 10μg per sample was used for the enzymatic analysis. The 533 
experiment was run in triplicate. A standard curve was prepared with Kdm1a assay buffer 534 
and assay standard solution, containing demethylated histone H3K4, diluted at concentration 535 
between 0.2 and 5 ng/μl. Sample wells were added with Kdm1a assay buffer, Kdm1a 536 
substrate (containing di-methylated histone H3K4) and 10μg of nuclear extract. No nuclear 537 
extract was added in blank wells. The strip-well microplate was covered with adhesive film 538 
to avoid evaporation, and incubate at 37°C for 2 h. At this stage, active Kdm1a binds to the 539 
substrate and removes methyl groups from the substrate. Then, the reaction solution was 540 
removed and each well washed three times with wash buffer. Capture antibody, that 541 
recognizes Kdm1a-demethylated products, was added to each well, the strip-well was 542 
covered with aluminum foil to protect from light and incubated at RT for 60 min. Antibody 543 
solution was removed and each well washed three times with wash buffer. Then, detection 544 
antibody was added to each well, covered again with aluminum foil and incubated at RT for 545 
30 min. Detection antibody solution was removed and each well was washed four times with 546 
wash buffer. Developer solution was added and the microplate incubated at RT for 10 min 547 
protected from light. In presence of methylated DNA, the solution will turn blue. At this 548 
point, stop solution was added to each well to quench the enzymatic reaction. Absorbance 549 
was read on a microplate reader Infinite M1000 (Tecan, Männedorf, Switzerland) at a 550 
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wavelength at 450 nm with an optional reference wavelength of 655 nm. The activity of 551 
Kdm1a enzyme is proportional to the optical density (OD) intensity measured. Accordingly, 552 
Kdm1a activity was calculated using the following formula:  553 
Kdm1a activity (OD/min/mg) = Sample OD – Blank OD/(Protein Amount (μg) x min). 554 
 555 
Kdm1a suppression 556 
The knockdown (KD) of kdm1a gene (NM_001242995.1) in zebrafish was achieved by 557 
injection of antisense morpholino (Mo) (Gene Tools, Philomath, Oregon) oligo targeting the 558 
mRNA AUG translational start site (sequence 5’-TTGGACAACATCACAGATGACAGAG-559 
3’). A 5-base pair mismatch Mo (sequence 5’-TTGcAgAACATgACAcATcACAGAG-3’) 560 
was used as control to detect possible off-target effects. A second antisense oligo targeting 561 
i3e4 splice junction of kdm1a, sequence 5'- CTACACCTGAGAAACCCAACATTTC-3' was 562 
used to corroborate data obtained with MOs that block translation.  563 
Using a standard microinjector (IM300 Microinjector; Narishige, Tokyo, Japan), an 564 
optimized dose of 0.4 ng (0.5nL bolus) of morpholino placed in a pulled glass capillary was 565 
injected in each embryo at 1–2 cell stage, just beneath the blastoderm.  566 
For KD of kdm1a in adult zebrafish, a vivo-Mo version was used, where the standard Mo is 567 
bound to a synthetic scaffold containing guanidinium groups as a delivery moiety in adult 568 
tissues. An antisense vivo-Mo that targets human b-globin intron mutation 5’-569 
CCTCTTACCTCATTACAATTTATA-3’ was used as negative control (Gene Tools LLC, 570 
Philomath, Oregon). Adult zebrafish were anesthetized in tricaine 0.05 mg/mL, and 2 μL of 571 
0.1 mmol/L vivo-Mo solution, previously loaded in a glass capillary, was injected into the 572 
retro-orbital vein, as previously described 41, on days 10, 8, 6, 4, 2 and 0 before tailfin 573 
amputation. 574 
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kdm1a construct 575 
A construct with kdm1a gene of Danio rerio (NM_001242995.1) was prepared to generate 576 
kdm1a modified (m) mRNA and was assembled from synthetic oligonucleotides. 577 
Modifications in the triplet code (n=7 silent mutations) were inserted in the sequence 578 
corresponding to the mRNA AUG translational start site (i.e. Mo binding site) to prevent Mo 579 
recognition in rescue experiments. The fragment was inserted in the pMA (GeneArt, 580 
Invitrogen, Carlsbad, CA) cloning vector and cloned in transformed Escherichia coli bacteria 581 
(strain K12/DH10B, Invitrogen, Carlsbad, CA) and then purified. The final construct was 582 
verified by sequencing and the sequence identity within the insertion site was 100%. 583 
 584 
Site-Directed Mutagenesis 585 
Site-directed mutagenesis of Kdm1a was carried out with Q5 Site-Directed Mutagenesis kit 586 
(New England Biolabs, Ipswich, MA, cat. E0554) according to manufacturers’ instructions. 587 
Standard primers for kdm1a were used for exponential amplification of the plasmid DNA (F 588 
5’-GACAGCCAGTCGAGGAGAAC-3’ and R 5’-TGCGACGTACGAGTATGAGC-3’), 589 
and mutagenic primers to create substitution of Cys334-to-Ala (C334A) in the plasmid were 590 
designed with the software NEBase Changer (F 5’-AAAACAGAAGGCTCCCCTCTATGA 591 
GGC-3’ and R 5’-ATCTTAGCCAGCTCCATATTG-3’). 592 
 593 
In vitro transcription of kdm1a 594 
Wild type and mutated kdm1a mRNA (C334A), with 7-methyl guanosine cap structure at the 595 
5´end and poly(A) tail at the 3´end, was transcribed from the constructs using HiScribe T7 596 
ARCA mRNA Kit (New England Biolabs, Ipswich, MA, cat. E2060) following 597 
manufacturers’ instructions. 598 
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Rescue of kdm1a knockdown by Kdm1a mRNA 599 
To determine whether the effects of the kdm1a KD on zebrafish embryos phenotype and 600 
tailfin regeneration were specifically due to loss of kdm1a, we co-injected kdm1a -Mo with 601 
kdm1a mRNA wild-type as a rescue. A bolus of 1 nl of solution containing 0.5 ng of kdm1a-602 
Mo a and 1 ng of Kdm1a RNA wild-type was injected into each egg. 603 
 604 
Rescue of kdm1a knockdown by kdm1a mRNA C334A 605 
Co-injection of kdm1a -Mo and kdm1a mRNA C334A was performed to assess whether the 606 
absence of the S-nitrosylated cysteine affected the ability of the mRNA to rescue phenotype 607 
and tailfin regeneration associated with kdm1a KD. A bolus of 1 nl of solution containing 0.5 608 
ng of kdm1a -Mo and 1 ng of kdm1a mRNA C334A was injected into each egg. 609 
 610 
Pharmacological modulation of S-nitrosylation 611 
Adult zebrafish were anesthetized in tricaine 0.05 mg/mL. A solution of 2 μL of iNos 612 
inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME, Sigma-Aldrich, St Louis, MO, cat. 613 
N5751) 10 or 50 mM diluted in sterile PBS (from stock solution of 250 mM), or of nitric 614 
oxide (NO) scavenger Phenyl-4,4,5,5-tetramethyl imidazoline-1-oxyl 3-oxide (PTIO, Sigma-615 
Aldrich, St Louis, MO, cat. P5084) 3 or 10 mM diluted in sterile PBS (from stock solution of 616 
100 mM), or of NO donor S-Nitroso-N-acetyl-DL-penicillamine (SNAP, Sigma-Aldrich, St 617 
Louis, MO, cat. N3398) 10 or 30 mM diluted in DMSO (from stock solution of 100 mM), or 618 
PBS as control, was loaded on a glass capillary, prepared in advance with a micropipette 619 
puller (Narishige, Inc., PC-10) and connected to a microinjector (IM300 Microinjector; 620 
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Narishige, Tokyo, Japan) and was injected into the retro-orbital vein as previously described 621 
41 on days 6, 4, 2 and 0 before tailfin amputation. 622 
The concentration of the Nos inhibitors, L-NAME and 1400W, were adopted after a pilot 623 
study with doses up to 250 mM. The survival was recorded and fish were monitored for any 624 
physical or behavioral abnormalities at a range of doses. For both compounds at a dose of 625 
250 nM, survival after 4 injections was approximately 40%, and lethargy and reduced swim 626 
were observed. At 150 mM the survival increased to 65% with no evident abnormal 627 
behaviour; whereas at 50mM, the dose e adopted for the study, the survival was 85% and no 628 
evident defects were observed (Fig. S2B).  629 
 630 
Optimisation of the injection procedure 631 
In our pilot studies, injection of physiological solutions every other day and alternating the 632 
eye at each injection reduced fish mortality. In this way, the effect of a drug on fish 633 
survival/mortality and phenotype can be better evaluated. Therefore, all the solutions of drugs 634 
were injected in the retro-orbital veins every other day and alternating the eyes, so that each 635 
eye was injected only twice at a distance of four days.   636 
 637 
Defining the zebrafish phenotype 638 
Whole embryo phenotype following Mo and mRNA treatments were described on the basis 639 
of the following morphologic features observed under bright-field microscopy: reduced body 640 
length, curved body, reduced swimming, chorionated larvae at 4 dpf, oedema. The phenotype 641 
was assessed using a simple six points scoring system, according to the severity of that 642 
feature and where one point was normal. At least four different clutches of larvae were 643 
assessed under each of the treatment groups. Data were reported graphically as divided in two 644 
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groups: normal, i.e. embryos not showing any abnormal features, and abnormal, i.e. embryos 645 
showing one or more of the features described above. 646 
 647 
Cardinal vein blood velocity  648 
Blood velocity was estimated in the posterior cardinal vein 42 by assessing frame by frame 649 
motion of single blood cells determined from video images captured in the zebrafish tail at 650 
the level of the cloaca. Four erythrocytes per fish (at least 5 embryos per group) over 10 651 
frames at video frame-rate of 30 frames per second (fps) were analyzed using ImageJ to 652 
determine mean blood cell velocity (μm·s−1).  653 
 654 
Kaplan-Meier analysis of survival 655 
Kaplan-Meier analysis was used to measure the survival of adult zebrafish or larvae 656 
following each defined treatment, using PRISM 7 software.  657 
 658 
Immunoprecipitation 659 
Immunoprecipitation experiments were performed using the Pierce Classic Magnetic IP/Co-660 
IP Kit (Thermo Fisher Scientific, San Jose, CA, cat. MAN0011737), according to 661 
manufacturer’s instructions.  662 
 663 
RNA extraction and quantitative PCR 664 
mRNA was extracted from embryos using column purification (RNeasy Mini Kit, Qiagen, 665 
Hilden, Germany, cat. 74104) according to the manufacturer’s instructions. Working surfaces 666 
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were cleaned with RNase Zap (Thermo Fisher Scientific, San Jose, CA, cat. AM9780) to 667 
deactivate environmental RNase. Efficient disruption and homogenization of tissue was done 668 
using sterile RNase-free disposable pestles (Thermo Fisher Scientific, San Jose, CA, cat. 12-669 
141-368) mounted on a cordless motor for 30 s and then passing the lysate 5-10 times 670 
through the needle (18-21 gauge) mounted on a RNAse free syringe. RNA integrity was 671 
assessed on basis of 18S and 28S ribosomal RNA (rRNA) bands. mRNA was reverse 672 
transcribed into cDNA using qScript cDNA Synthesis Kit (Quanta Bio, Beverly, MA, cat. 673 
95047), Primers (IDT Technologies, Coralville, Iowa) targeting genes of interest (see table 674 
S2) and SYBR Green PCR kit (Invitrogen, Carlsbad, CA) were used for real-time qPCR, that 675 
was performed with the QuantStudio 12 k Flex system (Applied Biosystems, Foster City, 676 
CA) following the manufacturer’s instructions. Gene expression was expressed as relative 677 
fold changes using the ΔCt method of analysis and normalized to β-actin.  678 
 679 
Western blotting 680 
Lysates containing 20μg of protein each were added with Laemmli buffer (4X) and deionised 681 
water to reach a final volume of 20μl. A sample containing pre-stained protein standard 682 
(BioRad, Hertfordshire, UK, cat. 1610375) was used to assess molecular mass of protein 683 
bands. Samples were heated at 95°C for 5 min and loaded on a polyacrylamide gel (4-15% 684 
gradient) (BioRad, Hertfordshire, UK, cat. 4561083). Electrophoresis was performed for 30 685 
min at a voltage of 100V and then for 60 min at 150V. Gels were transferred on PVDF 686 
membranes (Amersham Hybond, Sigma-Aldrich, St Louis, MO, cat. GE10600023) for 2 h at 687 
100V. Membranes were blocked with non-fat milk 5% in PBST (PBS+0.1% Tween) for 1h at 688 
RT and probed with primary antibody overnight at 4°C. Antibodies used were: Kdm1a rabbit 689 
polyclonal (1:200, Thermo Fisher Scientific, San Jose, CA, cat. PA1-41697); anti-iNos 690 
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mouse monoclonal (1:200, BD Transduction Laboratories, San Jose, CA, cat. 610432); anti-691 
β-tubulin rabbit polyclonal (1:500, Abcam, Cambridge, UK, cat. ab6046), Anti-Histone H3 692 
nuclear marker, rabbit polyclonal (1:500, Abcam, Cambridge, UK, cat. ab1791); anti-Histone 693 
H3 (1:500, unmodified Lys4), mouse monoclonal (1:500, Merck Millipore, Massachusetts, 694 
USA, cat. 05-1341); anti-monomethyl-Histone H3 (Lys4), rabbit polyclonal (1:500, Merck 695 
Millipore, Massachusetts, USA, cat. 07-436); anti-dimethyl-Histone H3 (Lys4), rabbit 696 
monoclonal (1:500, Merck Millipore, Massachusetts, USA, cat. 04-790); anti-monomethyl-697 
Histone H3 (Lys9), rabbit polyclonal (1:500, Merck Millipore, Massachusetts, USA, cat. 698 
ABE101); anti-dimethyl-Histone H3 (Lys9) rabbit polyclonal (1:500, Merck Millipore, 699 
Massachusetts, USA, cat. 07-212); anti-Rcor1 rabbit polyclonal (1:200, Invitrogen, Carlsbad, 700 
CA, cat. PA5-41564); anti-Hdac1 rabbit polyclonal (1:200, Abcam, Cambridge, UK, cat. 701 
ab33278); anti-Rbbp4 rabbit polyclonal (1:200, Biorbyt, Cat. orb583248); anti-Chd4 rabbit 702 
polyclonal (1:200, Biorbyt, Cambridge, UK, cat. orb575051); anti-TMT mouse monoclonal 703 
(1:200, Thermo Fisher Scientific, San Jose, CA, cat. 90075). Membranes were washed three 704 
times (5 min per wash) with PBS and incubated with HRP-conjugated goat anti-mouse 705 
(1:2000, Santa Cruz Biotechnology, Dallas, USA, SC-2005) or anti-rabbit (1:2000, Santa 706 
Cruz Biotechnology, Dallas, USA, SC-2004) antibodies for 1 h at RT. Then, membranes 707 
were washed again three times with PBS (5 min per wash). Antigen-antibody complexes 708 
were detected by incubation for 5 min to the enhanced chemiluminescence solution (ECL, 709 
Amersham) followed by exposure to a photographic film (BioMax XAR Film Kodak, Sigma-710 
Aldrich, St Louis, MO). The film was developed and band density was quantified by 711 
densitometry using ImageJ. β-tubulin and Histone H3 were used as loading control for 712 




Sequence and structural analysis of Kdm1a protein 716 
Similarities of zebrafish and human Kdm1a proteins were assessed using Protein Blast 717 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). Kdm1a crystal structure was obtained from the 718 
Protein Data bank (https://www.ebi.ac.uk/pdbe/entry/pdb/6nqm). 719 
 720 
Enzymatic isolation of endothelial cells from zebrafish tailfin 721 
Cells were isolated according to 43 with some modifications. In brief, amputated tailfin from 722 
adult Tg(fli1:EGFP)y1 zebrafish were placed in chilled PBS, washed with calcium-free 723 
Ringer solution (116 mM NaCl, 2.6 mM KCl, and 5 mM Hepes, pH 7.0), and replaced with 1 724 
mL solution of trypsin 0.25% (Gibco) added with 50 μg collagenase P (Roche) and 1 mM 725 
EDTA. Tissue was disaggregated first using fine scissors and then by pipetting the solution 726 
with a 200-μL pipette tip every 5 min for about 30 min. Cell suspensions were filtered 727 
through a 40-μm cell strainer (BD Biosciences) into FACS tubes. 728 
 729 
Flow cytometry characterization of fli1+ cells from zebrafish. 730 
Cell samples were run on a BD FACS Aria (BD Biosciences). FSC-H and FSC-A were used 731 
to select cell singlets; 4′,6-diamidino-2-phenylindole (DAPI) to select viable single cells; 732 
wild-type (Wik) zebrafish were used to set the gate between GFP− (i.e., fli1−) and GFP+ (i.e., 733 
fli1+) cells. At least 10,000 of fli1− and fli1+ cells (excitation [Ex]: 488 nm; emission [Em]: 734 
530 nm) were sorted into chilled PBS and 10% fetal bovine serum for further analysis. 735 
FlowJo 10 (Becton and Dickinson) was used to analyse data. 736 
 737 
Statistical analysis 738 
 32
Results were expressed as the mean ± SEM. Each experiment was performed 3 times 739 
(biological replicates). The Shapiro-Wilk test was used to confirm the null hypothesis that the 740 
data follow a normal distribution. Statistical comparisons between two groups or multiple 741 
groups were then performed, respectively, via Student t-test or ANOVA test using PRISM 7 742 
software followed by Bonferroni post hoc test. Log-rank test and Gehan-Breslow-Wilcoxon 743 
test were used for statistical analysis of the Kaplan-Meier curves. A P value <0.05 was 744 
considered significant. 745 
 746 
Reporting summary 747 
Further information on research design is available in the Nature Research Reporting 748 
Summary linked to this article. 749 
 750 
Data availability 751 
TMT-labelled S-nitrosylated protein analysis mass spectrometry data have been deposited to 752 
the ProteomeXchange Consortium via the MASSIVE repository (MSV000085055) with the 753 
dataset identifier PXD017883[https://www.ebi.ac.uk/pride/archive/projects/PXD17883] and 754 
are freely available. Furthermore, a full list of the S-nitrosylated proteins derived from the 755 
mass-spec is included in this manuscript as Dataset S1. Gene Expression Omnibus (GEO) 756 
database, accession 757 
GSE137971[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137971] was used for 758 
single cell sequencing analysis. All other relevant data supporting the key findings of this 759 
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Figure 1 – Modulation of Nos and nuclear protein S-nitrosylation during tailfin 888 
regeneration in adult zebrafish. A. Real time PCR for nos1, nos2a and nos2b in tailfin at 3, 889 
5, 10 dpa. B. Western blot (WB) analysis of Nos2 in tailfins at 3, 5 and 10 dpa and semi-890 
quantitative analysis of bands. C. WB analysis of Nos2 in nucleus and cytoplasm of tailfins at 891 
3, 5 and 10 dpa. Semi-quantitative analysis of bands shows nuclear to cytoplasmic protein 892 
ratio. D. WB analysis of S-nitrosylated nuclear proteins in the regenerating tailfin. S-893 
nitrosothiols were specifically labelled with TMT. An anti-TMT antibody was used to detect 894 
S-nitrosylated proteins. Neg and Pos are respectively the negative (without ascorbic acid) and 895 
positive (with S-nitrosoglutathione) controls. E-F. WB analysis of S-nitrosylated nuclear 896 
proteins in tailfin following treatment with L-NAME 10 or 50 mM, 2-Phenyl-4,4,5,5-897 
tetramethyl imidazoline-1-oxyl 3-oxide (PTIO) 3 or 10 mM, S-Nitroso-N-acetyl-DL-898 
penicillamine (SNAP) 10 or 30 mM, or PBS (control). The dot plot shows changes in tailfin 899 
regeneration rate, here shown at 7 dpa, following drug treatments compared to control. β-900 
tubulin was used as loading control for total or cytoplasmic proteins. Histone H3 was used as 901 
loading control for nuclear proteins. Dpa – days post-amputation. N=3 biological replicates, 902 
one way ANOVA test followed by Bonferroni’s multiple comparisons test was used to 903 
compare the means, p values shown are vs uninjured or control, all other comparisons are not 904 
significant. Data are presented as mean values +/- SEM. 905 
Figure 2 – Bioinformatic analysis of the S-nitrosylome in zebrafish tailfin regeneration. 906 
A. Workflow for the analysis of the S-nitrosylome. Tailfins of zebrafish (6 months old) were 907 
amputated; regrown tissue was collected in uninjured and at 3, 5 and 10 dpa (dash red lines 908 
represent the edge of the amputation); nuclear proteins were extracted and labelled with 909 
iodoTMT, digested with trypsin, and S-nitroso-peptides enriched through anti-TMT antibody 910 
containing resin and followed by LC-MS-MS. B-C. Hierarchical clustering heat map and 911 
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Venn diagram showing the dynamic changes in the number of S-nitrosylated nuclear proteins 912 
during the regeneration compared to uninjured. D. Hallmark pathways enrichment by the 913 
differentially expressed S-nitrosylated proteins during regeneration compared to uninjured. 914 
The significant pathways are displayed along the x-axis. Dpa - day post-amputation. N=2 915 
biological replicates, followed by bioinformatic analysis. 916 
Figure 3 – Role of S-nitrosylation of Kdm1a in tailfin regeneration in adult zebrafish. A. 917 
MS/MS fragmentation spectrum for the Cys334-containing peptide of Kdm1a. Peptide 918 
sequence is shown at the top left of the spectrum, with the annotation of the identified 919 
matched amino terminus-containing ions (b ions) in black and the carboxyl terminus-920 
containing ions (y ions) in red. The spectrum confirms the identity of the peptides CPLYEAN 921 
and the labeled C as S-nitrosylated cysteine.  B. Line graph reporting the quantification of 922 
Kdm1a S-nitrosylation (normalized by total Kdm1a) and Kdm1a activity during tailfin 923 
regeneration. C. Western blotting (WB) for S-nitrosylated Kdm1a in uninjured and at 3, 5 924 
and 10 dpa. Samples were previously immunoprecipitated (IP) for Kdm1a. IP with IgG and 925 
input were used as controls. D-E-F. WB for Kdm1a, CoRest and NuRD complexes 926 
components following IP with Kdm1a antibody in tailfin uninjured or injured at 5 dpa. Dpa – 927 
days post-amputation. N=3 biological replicates.  928 
Figure 4 – Effects of kdm1a knockdown in adult zebrafish. A. Western blotting (WB) 929 
analysis of Kdm1a control and morpholino KD. Dot plot shows semiquantitative analysis of 930 
bands. Two-tailed t-test. B. Effects of Kdm1a KD on tailfin regeneration. Dashed red line 931 
represents the edge of the resection. Scale bar indicates 2 mm. C. Line graph showing 932 
changes in tailfin regeneration rate following kdm1a KD. Two-way ANOVA followed by 933 
Bonferroni’s multiple comparisons test. D-E. WB for H3K4unme (unmethylated), H3K4me1, 934 
H3K4me2 and H3K4me3 in control uninjured, injured and injured + kdm1a KD at at 5 dpa. 935 
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Dot plot shows semi-quantitative analysis of bands. Histone H3 was used as loading control. 936 
Dpa - days post-amputation. Two-way ANOVA followed by Bonferroni’s multiple 937 
comparisons test, p values indicate comparisons of uninjured vs other groups. N=3 biological 938 
replicates. Data are presented as mean values +/- SEM. 939 
Figure 5 – Analysis of S-nitrosylation in endothelial cells during tailfin regeneration. A. 940 
Brightfield and fluorescence images of Tg(fli1:EGFP)y1 zebrafish tailfin at 3 days post-941 
amputation (dpa) showing formation of new vessel branches (GFP signal). Scale bar 942 
measures 500 μm. B. FACS plot of GFP+ and GFP- cells in the tailfin in control and during 943 
regeneration were separated by FACS. C. Quantification of GFP+ cells as shown in FACS 944 
plots. Two-tailed t-test. D. Western blotting (WB) of total S-nitrosylated proteins in zebrafish 945 
tailfin endothelial (GFP+) cells. E. WB of Kdm1a and S-nitrosylated Kdm1a in endothelial 946 
(GFP+) cells control, injury and injury + PTIO (NO scavenger) 10 mM. Dot plot shows semi-947 
quantitative analysis. p values vs 5 dpa group. F. Vessel density analysis in Tg(fli1:EGFP)y1 948 
zebrafish tailfin uninjured, injured and injured + PTIO 10 mM, measured as total length of 949 
vessels. G. ChIP-PCR analysis in GFP+ cells isolated from the regenerating tailfin showing 950 
H3K4me2-binding complex with vegfaa and tek promoters. Rabbit IgG were used as a 951 
negative control. H. Real time PCR analysis for endothelial genes in GFP+ cells from 952 
zebrafish control, injury and injury + PTIO 10 mM. Histone H3 was used as loading control. 953 
One-way ANOVA followed by Bonferroni’s multiple comparisons test, p values indicate 954 
comparisons vs uninjured. N=3 biological replicates. Data are presented as mean values +/- 955 
SEM. 956 
Figure 6. Modulation of Kdm1a S-nitrosylation during tailfin regeneration. A. Kdm1a 957 
mRNA C334A was generated by site-directed mutagenesis, replacing the aa Cys334 with 958 
Ala. B-D. Zebrafish embryos injected with kdm1a morpholino (Mo), or co-injected with 959 
 41
kdm1a Mo with kdm1a mRNA C334A or wild type. B. Western blotting and semi-960 
quantitative analysis showed the effective knockdown and rescue of kdm1a following the 961 
different treatments. β-tubulin was used as loading control. C-D. Images and dot plot of 962 
tailfin regeneration following kdm1a modulation (P values vs control). Scale bar measures 963 
100 μm. E. Working model. Tissue injury promotes the S-nitrosylation of the Cys334 of 964 
Kdm1a. S-nitrosylated Kdm1a detaches from the CoRest complex and loses its demethylase 965 
activity on H3K4. One-way ANOVA followed by Bonferroni’s multiple comparisons test, p 966 
values indicate comparisons vs control. N=3 biological replicates. Data are presented as mean 967 
values +/- SEM. 968 
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